This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TERLIVAZ 0.85 MG VIALS, a pharmaceutical product, with a ceiling value of $29,548.32 and a performance period through May 12, 2025. The contract is a firm fixed-price delivery order, which is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a...
This federal contract award, valued at $12,311.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TERLIVAZ 0.85 MG VIALS, a pharmaceutical product, with a completion date of June 13, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00, which provides a comprehensive global pharmaceutical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,963.18, is for the delivery of TALVEY 40 MG/ML VIALML medical supplies. The contract is a firm fixed-price delivery order with a completion date of July 9, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a $6,981.59 firm fixed-price delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TALVEY 40 MG/ML VIALML, a medical product, with a performance period through June 10, 2025. Amerisourcebergen Drug Corp is a for-profit organization that holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $2,733.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4564977921 TALVEY 3 MG/1.5 ML VIAL 1.5ML, a pharmaceutical product. The contract has an ultimate completion date of July 15, 2024 and is a Firm Fixed Price Delivery Order. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,974.30 firm fixed-price contract provides for the delivery of 180 mg vials of the drug TRODELVY. The contract has an ultimate completion date of April 2, 2025 and was awarded on March 12, 2025. This order is part of AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,494.30, is for the delivery of TALVEY 3 MG/1.5 ML VIAL 1.5ML, a medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 9, 2025. The contract is not designated with a set-aside requirement, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of medical vials. The contract has a ceiling value of $1,624.00 and a period of performance ending on September 13, 2024. This contract is not set aside for any specific business type. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TIVDAK 40 MG VIALS, a pharmaceutical product, with a firm fixed price of $13,083.75 and a completion date of April 23, 2025. The contract is not set-aside and represents open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,511.36, is for the delivery of medical vials. It is a firm fixed-price contract with an ultimate completion date of September 16, 2022. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a for-profit organization that has been registered in the System for Award...